4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-19-043346
CIK 0001641640other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:20 PM ET
Size
5.3 KB
Accession
0001104659-19-043346
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Stock Option
2019-07-31+35,000→ 35,000 totalExp: 2029-07-31→ Ordinary Shares (35,000 underlying)
Footnotes (2)
- [F1]The exercise price is $2.38 per share.
- [F2]This option was granted on July 31, 2019. One hundred percent (100%) of the option will vest on July 31, 2020, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:20 PM ET
- Size
- 5.3 KB